Law Office of Brodsky & Smith, LLC Announces Investigation of Artio Global Investors, Inc.
BALA CYNWYD, Pa., Feb. 14, 2013 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Artio Global Investors, Inc. ("Artio Global" or the "Company") (NYSE: ART) relating to the proposed acquisition by Aberdeen Asset Management PLC ("Aberdeen").
Under the terms of the transaction, Artio Global shareholders will receive only $2.75 in cash for each share of Artio Global stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Artio Global for not acting in the Company's shareholders' best interests in connection with the sale process to Aberdeen. The transaction may undervalue the Company and will result in a loss for many long term shareholders. For example Artio Global stock traded at $3.54 as recently as July 2, 2012 and $17.82 on April 12, 2011.
If you own shares of Artio Global stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at email@example.com visiting http://brodsky-smith.com/542-art-artio-global-investors-inc.html, by calling toll free 877-LEGAL-90.
SOURCE Law Office of Brodsky & Smith, LLC
More by this Source
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Vocus, Inc. - VOCS
Apr 07, 2014, 22:05 ET
SHAREHOLDER ALERT: Proposed Buyout of Schawk, Inc. May Be Unfair For Shareholders - SGK
Mar 17, 2014, 12:33 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.